The M1 MacBook Air is back at its all-time low price

Sumitomo Rubber Industries has ambitious plans to reduce its emissions by half compared with 2017 levels in 2029 and achieve carbon neutrality in 2050

Vaccines are life saviors but making and testing new vaccines is a complex process that mostly involves a series of animal trials.vaccines can be screened using organoids —- lab-grown cell clusters that collectively behave like a mini organ.

these findings highlight the potential of synthetic organoids for rapidly predicting conjugate vaccine efficacy as well as expediting antigen-specific antibody discovery.The mini-organs developed by researchers during the study are made up of a hydrogel matrix comprising B cells extracted from mice spleens and some signaling molecules. How does a mini organ test vaccines?Diagram depicting the lab-grown mini organoid (below the mouse).

Humans can catch this disease either by coming in contact with an infected rabbit or by the bite of a fly carrying the bacteria.Then they test the vaccine on other animals and this process is repeated until the vaccine becomes 100 percent safe for human trials.

greatly increasing testing throughput — which could help researchers keep up with the large numbers of compounds they can create and need to screen.

the immune system directs its B cells (a type of white blood cell) to start producing antibodies to kill the antigens.AI adoption has exploded and amplified the need for a coherent IT strategy.

Together with radical collaboration.the speakers highlighted the societal leadership challenges posed by AI and that leaders have a duty to support their workforce through AI adoption with empathy.

while promoting psychological safety.leaders can guide their organizations through the AI-driven transformation in a productive way.